Login
Evogene Ltd. logo

Evogene Ltd.

evogene.com

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 142 full-time employees. The company went IPO on 2007-06-11. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Financial Snapshot

Revenue
TTM
$1.307M
Gross Margin
TTM
54.57%
Net Income
TTM
-$9.073M
Current Assets
2026 Q2
$10.85M
Current Liabilities
2026 Q2
$3.044M
Current Ratio
2026 Q2
356.57%
Total Assets
2026 Q2
$13.44M
Total Liabilities
2026 Q2
$16.73M
Book Value
2026 Q2
-3.290M
Cash
2026 Q2
$9.316M
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$10.97M

Stock Price

Loading...
Market Cap: $8.4996 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support